Alberto Corsini researcher
Corsini, Alberto
Corsini, A.
VIAF ID: 23803649 (Personal)
Permalink: http://viaf.org/viaf/23803649
Preferred Forms
- 100 0 _ ‡a Alberto Corsini ‡c researcher
-
-
- 100 1 0 ‡a Corsini, Alberto
-
- 100 1 _ ‡a Corsini, Alberto (sparse)
-
- 100 1 _ ‡a Corsini, Alberto
- 100 1 _ ‡a Corsini, Alberto
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
2-Amino-3-(phenylsulfanyl)norbornane-2-carboxylate: an appealing scaffold for the design of Rac1-Tiam1 protein-protein interaction inhibitors | |
Ability of the LDL receptor from several animal species to recognize the human apo B binding domain: studies with LDL from familial defective apo B-100. | |
Acute heart failure in patients with acute aortic syndrome: pathophysiology and clinical-prognostic implications | |
Association of physicians’ accuracy in recording with quality of care in cardiovascular medicine | |
Atorvastatin reduces long pentraxin 3 expression in vascular cells by inhibiting protein geranylgeranylation. | |
Biomarkers for atherosclerosis: pathophysiological role and pharmacological modulation. | |
Bococizumab for the treatment of hypercholesterolaemia. | |
Cholesterol and mevalonic acid modulation in cell metabolism and multiplication | |
Cholesterol stimulation of HDL binding to human endothelial cells EAhy 926 and skin fibroblasts: evidence for a mechanism independent of cellular metabolism | |
Clinical and biochemical characterisation of patients with autosomal recessive hypercholesterolemia (ARH) | |
Colesevelam hydrochloride: usefulness of a specifically engineered bile acid sequestrant for lowering LDL-cholesterol. | |
Current challenges and controversies in drug-induced liver injury. | |
Do structural differences in statins correlate with clinical efficacy? | |
Drug attrition during pre-clinical and clinical development: understanding and managing drug-induced cardiotoxicity. | |
Drug-drug interactions with statins: will pitavastatin overcome the statins' Achilles' heel? | |
Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease. | |
Effect of atherogenic lipoproteins on PAI-1 synthesis by endothelial cells | |
Effect of S | |
Effect of the nifedipine-atenolol association on arterial myocyte migration and proliferation | |
ETC-1002 (Bempedoic acid) for the management of hyperlipidemia: from preclinical studies to phase 3 trials | |
Everolimus inhibits monocyte/macrophage migration in vitro and their accumulation in carotid lesions of cholesterol-fed rabbits. | |
Experimental studies on the hypolipidemic activity of chloridarol | |
Fibrillar collagen inhibits cholesterol biosynthesis in human aortic smooth muscle cells. | |
Fluid–Structure Computational Analysis to Investigate the Link between Early Atherogenic Events and the Hemodynamic Environment in an Experimental Model of Intimal Thickening | |
Free cholesterol alters macrophage morphology and mobility by an ABCA1 dependent mechanism | |
High density lipoproteins, c1993: | |
Impact of physicians' age on the clinical management of global cardiovascular risk: analysis of the results of the Evaluation of Final Feasible Effect of Control Training and Ultra Sensitisation Educational Programme. | |
Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency. | |
Influence of trapidil and derivatives on cholesterol synthesis and esterification in cultured cells | |
Inhibitory effect of PCSK9 on Abca1 protein expression and cholesterol efflux in macrophages. | |
Isothiazoles. Part XV. A mild and efficient synthesis of new antiproliferative 5-sulfanylsubstituted 3-alkylaminoisothiazole 1,1-dioxides | |
Lipid lowering drugs and inflammatory changes: an impact on cardiovascular outcomes? | |
Multidimensional approach for the proper management of a complex chronic patient with chronic obstructive pulmonary disease. | |
New insights into the pharmacodynamic and pharmacokinetic properties of statins | |
New Ras CAAX mimetics: design, synthesis, antiproliferative activity, and RAS prenylation inhibition | |
Nitric oxide-donating atorvastatin attenuates neutrophil recruitment during vascular inflammation independent of changes in plasma cholesterol | |
Nuevos conocimientos sobre las propiedades farmacodinámicas y farmacocinéticas de las estatinas | |
Nutraceuticals and functional foods for the control of plasma cholesterol levels. An intersociety position paper | |
Oxidized LDL-dependent pathway as new pathogenic trigger in arrhythmogenic cardiomyopathy | |
PCSK9 antagonists and inflammation. | |
Perivascular carotid collar placement induces neointima formation and outward arterial remodeling in mice independent of apolipoprotein E deficiency or Western-type diet feeding | |
Pharmacological interactions of statins. | |
Pharmacology of dipeptidyl peptidase-4 inhibitors: similarities and differences. | |
[Polytherapy and polypharmacy in elderly patients with chronic heart failure] | |
Potential statin drug interactions in elderly patients: a review | |
Purification and In Vitro Evaluation of an Anti-HER2 Affibody-Monomethyl Auristatin E Conjugate in HER2-Positive Cancer Cells | |
Raloxifene elicits combined rapid vasorelaxation and long-term anti-inflammatory actions in rat aorta. | |
Raloxifene inhibits matrix metalloproteinases expression and activity in macrophages and smooth muscle cells. | |
Relationship between mevalonate pathway and arterial myocyte proliferation : in vitro studies with inhibitors of HMG-CoA reductase | |
Risk for myopathy with statin therapy in high-risk patients. | |
The role of mitochondria in statin-induced myopathy | |
Rosuvastatin displays anti-atherothrombotic and anti-inflammatory properties in apoE-deficient mice. | |
The safety of HMG-CoA reductase inhibitors in special populations at high cardiovascular risk | |
Simvastatin but not pravastatin has a direct inhibitory effect on rat and human myocyte proliferation | |
Simvastatin reduces MMP1 expression in human smooth muscle cells cultured on polymerized collagen by inhibiting Rac1 activation | |
Statin drug interactions and related adverse reactions: an update. | |
Statin-related muscle complaints: an underestimated risk | |
Statins effect on smooth muscle cell proliferation. | |
Synthesis, structural, and biological evaluation of bis-heteroarylmaleimides and bis-heterofused imides | |
Synthetic peptides containing a conserved sequence motif of the Id protein family modulate vascular smooth muscle cell phenotype | |
Thiazole- and imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase | |
Tratado de Lisboa | |
Trattato di Lisbona Carta dei diritti fondamentali dell'Unione Europea | |
Treatment of dyslipidemia in kidney transplantation | |
Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) by 15-lipoxygenase-modified LDL in endothelial cells | |
Virtual screening approach for the identification of new Rac1 inhibitors |